Figure 3.
IFN-γ–inducible plasma proteins are significantly increased in HLH. Boxplots demonstrate comparisons of specific analyzes in HLH, SIRS/sepsis, and control groups in training (i) and validation (ii) cohorts. Bars with asterisk indicate groups with statistically significant differential expression evaluated using a Mann-Whitney-Wilcoxon test (P < .05). IFN-γ–inducible plasma proteins CXCL9, CXCL10, and CXCL11 are significantly increased in HLH compared with sepsis in training and validation cohorts. IL-6 is relatively increased in SIRS/sepsis compared with HLH, and there is no significant difference in IL-10 concentrations in HLH and SIRS/sepsis in the validation cohort in this study.

IFN-γ–inducible plasma proteins are significantly increased in HLH. Boxplots demonstrate comparisons of specific analyzes in HLH, SIRS/sepsis, and control groups in training (i) and validation (ii) cohorts. Bars with asterisk indicate groups with statistically significant differential expression evaluated using a Mann-Whitney-Wilcoxon test (P < .05). IFN-γinducible plasma proteins CXCL9, CXCL10, and CXCL11 are significantly increased in HLH compared with sepsis in training and validation cohorts. IL-6 is relatively increased in SIRS/sepsis compared with HLH, and there is no significant difference in IL-10 concentrations in HLH and SIRS/sepsis in the validation cohort in this study.

Close Modal

or Create an Account

Close Modal
Close Modal